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 Cardiac troponins and NT-proBNP may be reliably measured in postmortem serum from femoral 
blood 
 Postmortem intervals over 48 h may cause increased levels of cardiac troponins in postmortem 
serum from femoral blood 





The possible use of biochemical markers in the postmortem diagnosis of myocardial ischemia is well 
known in the forensic setting, though several issues have limited its widespread adoption. The study 
presented herein focuses of N-terminal pro-B-type natriuretic peptide, troponin T, and troponin I, and 
the possible influence due to sampling site chosen, postmortem interval elapsed, and cardiopulmonary 
resuscitation attempts. Comparisons were performed between antemortem serum levels of these 
markers  and postmortem levels measured in pericardial fluid and postmortem serum samples obtained 
from different sampling sites (n = 16). Levels of these markers were also compared in cases 
characterized by various postmortem intervals (n = 48, consisting of 24 ischemic heart disease cases and 
24 controls) as well as in cases with and without cardiopulmonary resuscitation (n = 22, consisting of 14 
cases of hanging and 8 cases of drug intoxication). Our results indicate that N-terminal pro-B-type 
natriuretic peptide, troponin T, and troponin I values determined in postmortem serum from femoral 
blood (collected up to 24 h after death) do not differ significantly from those measured in venous blood 
antemortem serum samples (collected at the upper limbs). In addition, our results reveal that the time 
elapsed after death should always be taken into consideration when cardiac troponins are measured in 
postmortem samples. Lastly, our findings reveal the absence of statistically significant differences 
between levels of the tested biomarkers (in postmortem serum from femoral blood) in cases without 
cardiopulmonary resuscitation compared to cases with cardiopulmonary resuscitation (at least for 

















The possible use of biochemical markers (cardiac troponins, natriuretic peptides, myoglobin and myosin 
as well as lactate dehydrogenase (LDH) and creatine kinase (CK) isoenzymes) in the postmortem 
diagnosis of myocardial ischemia, whether or not combined with complementary investigations (such as 
immunohistochemistry and radiological examinations with contrast material injection) is well known 
and surely not novel in the forensic setting [1-35]. 
Nevertheless, use of such analyses seems to have been confined to only some research teams over the 
years and has never actually spread among forensic pathologists.  This lack of widespread use may be 
for a myriad of reasons. The first and most important is surely the challenge of identifying the most 
reliable combination of biomarkers and, above all, the most suitable biological sample(s) to collect at 
autopsy for their analysis. Choices of various possible specimens have broadened over time, including 
femoral vein blood, external iliac vein blood, left heart blood, right heart blood, vitreous humor as well 
as pericardial and cerebrospinal fluid, with results that may prove conflicting or inconclusive at times. 
The second issue is undoubtedly the difficulty of determining ranges of plausible diagnostic values 
according to postmortem intervals and chosen biological samples, since the onset of decompositional 
changes might be characterized by unpredictable leakage into the circulation and/or extracellular fluid 
of numerous molecules from cells whose membrane integrity might have been damaged, compromised, 
or disrupted after death, including myocytes. 
The third and not least significant reason is undeniably the difficulty of clearly defining the weight and 
role played by eventual cardiopulmonary resuscitation in inducing increases in cardiac biomarker levels 
(in blood and/or other biological fluids) exclusively due to the release of intracellular molecules 
following cardiac massage regardless of whether genuine myocardial ischemia was present or not. 
Although various, promising investigations have been performed over the course of time in the forensic 
setting, the challenging issues aforementioned (biomarker type, sampling site, postmortem interval, and 
cardiopulmonary resuscitation influences) have never been analyzed simultaneously in the same study. 
 
The purpose of the paper presented herein is threefold:  
 
- to determine N-terminal pro-B-type natriuretic peptide (NT-proBNP), troponin T, and troponin I 
in a series of cases that underwent forensic investigations, with antemortem serum (from 
peripheral blood collected at the upper limbs at hospital admission) and a series of postmortem 
samples available for comparison, thereby investigating the postmortem distribution of these 
molecules after death and identifying the most suitable biological sample(s) to collect at 
autopsy, 
 
- to determine the same molecules in a series of cases that underwent forensic investigations 
including ischemic heart disease (microscopically identified) deaths and controls (drug 
intoxication and hanging cases without ischemic heart disease) characterized by various 
postmortem intervals, thereby investigating the stability of these molecules according to the 
time elapsed after death, 
 
- to measure the same molecules in a series of cases that underwent forensic investigations, with 
and without cardiopulmonary resuscitation (first aid cardiopulmonary resuscitation without 











cardiopulmonary resuscitation in changing concentrations of these molecules regardless of the 
presence of authentic myocardial ischemia. 
 
2 Materials and methods 
 
2.1 Study design and study populations 
 
The present study was performed during 2010-2017. All selected cases originated from forensic practice 
and underwent medicolegal investigations as requested by local inquiring authorities (the public 
prosecutor). Laboratory analyses were performed as part of the medicolegal investigations. 
 
To address the first aim of the study, comparisons between antemortem and postmortem 
concentrations of NT-proBNP, troponin T, and troponin I were performed on samples collected from 16 
individuals (11 males and 5 females, mean age 41.4 years) who had been admitted to hospital shortly 
prior to death. 
Diagnosis on hospital admission consisted of sudden loss of consciousness in the presence of witnesses. 
Death was pronounced within 10 h of patient hospitalization. The corpses were transferred to the 
medicolegal centre for further investigations. Complete medicolegal autopsies were performed between 
18 and 24 h after death. The causes of death were determined to be drug intoxication in all cases and 
were unrelated to chest trauma. 
Antemortem samples consisted of serum obtained from venous blood collected from the upper limbs 
between 2 and 4 h prior to death. 
Postmortem samples for comparison consisted of postmortem serum obtained from blood sampled at 
different sampling sites (right atrium, left atrium, right ventricle, left ventricle, ascending aorta, carotid 
artery, subclavian artery, jugular vein, subclavian vein, and femoral vein) as well as pericardial fluid. 
 
Case inclusion criteria for this study group consisted of: 
 
- availability of antemortem serum samples collected from the upper limb(s) at hospital 
admission, 
- antemortem serum samples collected during hospitalisation between 2 and 4 h prior to death, 
- interval between death and postmortem sample collection not exceeding 24 h, 
- availability of all postmortem samples at autopsy, 
- causes of death unrelated to chest trauma. 
 
To address the second aim of the study, concentrations of NT-proBNP, troponin T, and troponin I were 
measured in postmortem serum from femoral blood (based on the results of the first aim of the study) 
in a series of cases of ischemic (coronary) heart disease (microscopically identified) and non-ischemic-
heart-disease cases (including cases of hanging and drug intoxication) characterized by various 
postmortem intervals. 
The ischemic (coronary) heart disease cases consisted of 24 individuals (18 males and 6 females, mean 
age 49.3 years), 8 of whom characterized by postmortem intervals ranging from 4 to 24 h, a further 
subgroup of 8 characterized by postmortem intervals ranging from 25 to 48 h, and the last subgroup by 
postmortem intervals ranging from 49 to 72 h. 
The non-ischemic-heart-disease cases consisted of 24 individuals (20 males and 4 females, mean age 
44.2 years, 10 cases of hanging and 14 of drug intoxication). 8 out of 24 cases were characterized by 











intervals ranging from 25 to 48 h, and the last subgroup of cases by postmortem intervals ranging from 
49 to 72 h. 
Complete medicolegal autopsies were performed between 4 and 72 h after death. In all cases, the cause 
of death was unrelated to chest trauma. 
 
Case inclusion criteria for this study group consisted of: 
 
- postmortem interval not exceeding 72 h, 
- availability of postmortem serum from femoral blood at autopsy, 
- causes of death unrelated to chest trauma, 
- postmortem investigation findings supporting the hypothesis of ischemic heart disease death 
(for the first group) and the hypothesis of drug intoxication or mechanical asphyxia following 
external, mechanical force applied to the neck region (for the second group), 
- postmortem investigation findings excluding the hypothesis of ischemic (coronary) heart disease 
death in the second group. 
 
To address the third aim of the study, concentrations of NT-proBNP, troponin T, and troponin I were 
measured in postmortem serum from femoral blood (based on the results of the first aim of the study) 
in a series of 22 forensic cases (15 males and 7 females, mean age 50.2 years) including: 
 
- 7 cases of hanging with postmortem intervals up to 24 h and cardiopulmonary resuscitation 
attempts (first aid cardiopulmonary resuscitation, external heart massage, without 
defibrillation), 
- 7 cases of hanging with postmortem intervals up to 24 h without cardiopulmonary resuscitation, 
- 8 cases of drug intoxication with postmortem intervals up to 24 h without cardiopulmonary 
resuscitation. 
 
Case inclusion criteria for this study group consisted of: 
 
- postmortem intervals up to 24 h, 
- availability of postmortem serum from femoral blood at autopsy, 
- causes of death unrelated to chest trauma, 
- postmortem investigation findings excluding the hypothesis of ischemic (coronary) heart disease 
death in all cases, 
- postmortem investigation findings supporting the hypothesis of drug intoxication or mechanical 
asphyxia following external, mechanical force applied to the neck region. 
 
2.2 Postmortem investigations and sample collection 
 
Medicolegal autopsies, histology, toxicology and biochemical investigations were performed in all cases. 
Conventional histology included haematoxylin-eosin (HE) stains of brain, heart, lung, liver, and kidney. 
Hearts were sectioned before or after fixation in 10% neutral buffered formalin. Full thickness areas 
involving the left anterior, the lateral free wall, and left posterior ventricle as well as the interventricular 
septum and right anterior ventricle were systematically sampled. The major epicardial coronary arteries 
were either serially sectioned at approximately 2-mm intervals or longitudinally sectioned intact on the 
heart. In selected cases, coronary arteries were removed from the heart and retained for decalcification 
prior to dissection. In selected cases, histological sections of the coronary arteries were prepared at 











Systematic toxicological analysis included blood ethanol level determination as well as general screening 
for volatile and nonvolatile drugs, poisons, and metabolites. 
Femoral blood samples for toxicological and biochemical investigations were collected prior to autopsy 
by aspiration with sterile needles and syringes from the femoral vein(s). Blood samples were drawn after 
clamping the vein(s) at the proximal end and keeping the lower limb(s) raised for several minutes. 
Samples were stored in tubes containing sodium fluoride and preservative-free gel serum separator 
tubes. The latter were centrifuged immediately post collection at 3000 g for 15 min. After 
centrifugation, the separated supernatant (postmortem serum) was collected and stored in 
preservative-free tubes. No specimens were excluded due to insufficient sample volume. Postmortem 
serum samples were transferred to the laboratories immediately post collection. When analyses were 
delayed, samples were stored at - 20°C. 
Right atrium blood, left atrium blood, right ventricle blood, left ventricle blood, ascending aorta blood, 
carotid artery blood, subclavian artery blood, jugular vein blood, subclavian vein blood, and pericardial 
fluid samples were collected during autopsy by aspiration with sterile needles and syringes, stored 
immediately in preservative-free gel serum separator tubes and centrifuged immediately post collection 
at 3000 g for 15 min. After centrifugation, the separated supernatant was collected and stored in 
preservative-free tubes. No specimens were excluded due to insufficient sample volume. Postmortem 
samples were transferred to the laboratories immediately post collection. When analyses were delayed, 
samples were stored at - 20°C. 
 
2.3 Laboratory assays 
 
Cardiac troponin I was analyzed with the Access® AccuTnITM Immunoassay on Access II (Beckman 
Coulter, Fullerton, CA, USA). Results were expressed in µg/l. The clinical reference value (according to 
the laboratory where the analysis was performed) was 0.03 µg/l (corresponding to 0.03 ng/ml). 
Levels of cardiac troponin T were measured with hs-TnT reagents by electrochemiluminescence 
immunoassay (ECLIA). Results were expressed in ng/l. The clinical reference value (according to the 
laboratory where the analysis was performed) was 14 ng/l. 
NT-proBNP levels were measured with the commercially available immunoassays on the Roche Modular 
E170 system (Roche Diagnostics GmbH, Mannheim, Germany). Results were expressed in ng/l. The 
clinical reference value (according to the laboratory where the analysis was performed) was 738 ng/l 
(corresponding to 738 pg/ml and 87 pmol/l). 
 
2.4 Statistical analysis 
 
Comparisons were performed using the non-parametric Mann-Whitney U test. Statistical significance 
was defined as a P value of less than 0.05. All statistical analyses were performed using GraphPad Prism 




3.1 Postmortem distribution of troponin T, troponin I, and NT-proBNP 
 
No statistically significant differences were noticed between antemortem serum and postmortem serum 
(obtained from femoral blood) levels of all tested markers (P > 0.05 for all comparisons). On the 
contrary, statistically significant differences were found between antemortem serum and pericardial 











(from all other sampling sites) concentrations of all measured parameters (P < 0.05 for all comparisons 
in all fluids).  
Levels of both troponins I and T in pericardial fluid were up to 100 times greater than those measured in 
postmortem serum from femoral blood. Analogously, pericardial fluid NT-proBNP concentrations were 
up to 35 times greater than those measured in postmortem serum from femoral blood. 
The highest levels of troponins I and T were found (in the order) in postmortem serum obtained from 
left ventricle blood, ascending aorta blood, carotid artery blood, subclavian artery blood, right ventricle 
blood, right atrium blood, and left atrium blood. Comparable concentrations of troponins I and T were 
measured in postmortem serum obtained from right atrium blood, jugular vein blood, and subclavian 
vein blood.  
 
3.2 Stability of troponin T, troponin I, and NT-proBNP according to postmortem intervals 
 
The measured values of troponin T, troponin I, and NT-proBNP in all studied groups and subgroups are 
reported in Table 1. 
As shown, postmortem intervals greater than 48 h were characterized by troponin T and I values in 
postmortem serum from femoral blood over 1000 ng/l and 100 µg/l, respectively, regardless of an 
ischemic or non-ischemic cause of death.  
No statistically significant differences were noticed in troponin T, troponin I, and NT-proBNP levels 
between the 4-24 h and the 25-48 h subgroups of both ischemic and non-ischemic causes of death, 
which would suggest postmortem stability of all these molecules in postmortem serum from femoral 





3.3 Role of cardiopulmonary resuscitation 
 
No statistically significant differences were noticed among levels of all tested biomarkers (measured in 
postmortem serum from femoral blood) in hanging and drug intoxication cases without 
cardiopulmonary resuscitation versus hanging cases with cardiopulmonary resuscitation and 
postmortem intervals up to 24 h (P > 0.05 for all comparisons). 
These findings wound indicate that cardiopulmonary resuscitation (external heart massage without 
defibrillation) is not associated with postmortem increases in troponin T, troponin I, and NT-proBNP 
levels in postmortem serum from femoral blood (in those cases that had postmortem intervals up to 24 




In the realm of forensic pathology, numerous studies have been carried out over time in order to assess 
whether cardiac proteins (troponins, natriuretic peptides, myosin, myoglobin, cathepsin D, as well as 
lactate dehydrogenase and creatine kinase isoenzymes) measured in various biological fluids collected 














Most of these studies focused on the analysis of cardiac proteins and enzymes in blood and pericardial 
fluid, whereas comparisons between antemortem and postmortem blood/serum concentrations were 
undertaken exceptionally. 
Davies et al. [17] have been among the few authors to measure cardiac troponin levels in blood taken 
from patients shortly before death (antemortem samples retrieved from hospital clinical biochemistry 
laboratory) and compare them to postmortem values obtained in blood sampled from different sites 
(heart, superior vena cava, iliac and femoral veins) and at different intervals during the early 
postmortem period. Though erratic results bearing little or no relation to antemortem troponin levels 
were obtained for all involved individuals, these researchers still highlighted the potential usefulness of 
cardiac troponin measurement in the postmortem setting to support the diagnosis of cardiac death in 
selected cases. 
The review of pertinent papers covering the value of cardiac protein determination in various 
postmortem samples has shown that a large majority of authors identified pericardial fluid as the 
(postmortem) biological specimen with the highest (or one of those with the highest) diagnostic 
reliability to support a postmortem diagnosis of myocardial ischemia [1-4, 6-9, 15, 16, 18-20, 23, 27-
29,32,34]. 
At the same time, a portion of researchers expressed concerns with using (postmortem) pericardial fluid 
to confirm the diagnosis of myocardial ischemia arising from the fact that troponin concentrations in this 
sample appeared to be significantly higher (of several orders of magnitude) than those expected in 
blood or serum (and higher than the concentrations obtained in pericardial fluid sampled from patients 
undergoing coronary artery bypass surgery) [12]. The alleged reason for the elevated troponin levels in 
pericardial fluid would be linked to the close proximity of the myocardium to the pericardium and the 
consequent, possible direct leakage of myocardial proteins into pericardial fluid in the early postmortem 
period [12, 34]. 
An analogous consideration (the adjacency of the left ventricle myocardium to ventricular blood and 
eventual egress of myocardial proteins directly into heart blood after death due to the onset of 
decompositional changes) could also account for the fact that, in our study, the highest levels of 
troponins and NT-proBNP were found in postmortem serum obtained from left ventricle, ascending 
aorta, carotid artery blood, and subclavian artery blood. 
It must also be highlighted that Gonzalez-Herrera et al. [34], who are authors of one of the most recent 
articles on this topic based on the use (for the first time) of a highly sensitive cardiac troponin assay, 
found that average levels of cardiac troponin T in postmortem serum from femoral blood were markedly 
higher than those measured in clinical serum using the same highly sensitive assay. 
The results of our own investigations tend to indicate that NT-proBNP, troponin T, and troponin I values 
determined in postmortem serum from femoral blood (collected up to 24 h after death) do not differ 
significantly from those measured in venous blood antemortem serum samples (collected at the upper 
limbs).  
These preliminary results seem to suggest alternative conclusions to those reported by Davies et al. [17] 
(absence of relationship between antemortem and postmortem serum troponin levels) and Gonzalez-
Herrera et al. [34], (higher troponin T levels in postmortem serum from femoral blood compared to 
antemortem serum) and would confirm, on the contrary, one of the statements in the study by Batalis 
et al. [27]. These authors identified the combination cardiac troponin I-femoral vein blood as one of the 
sampling site-cardiac protein combinations with a statistically significant difference between ischemic 
heart disease cases and control cases. 
Another point that deserves emphasis is that Gonzalez-Herrera et al. [34] identified a troponin T cut-off 
point of 3200 ng/l in pericardial fluid, and 250 ng/l in postmortem serum from femoral blood, for the 
diagnosis of sudden cardiac death. This latter value is very close to the highest troponin T concentrations 











ischemia with postmortem intervals up to 48 h (41-242 ng/l in the ischemia group with postmortem 
intervals up to 24 h and 46-236 ng/l in the ischemia group with postmortem intervals up to 48 h, with no 
statistically significant differences between the two groups). 
The reason why our analyses have shown uninterpretable troponin T and I values in postmortem serum 
from femoral blood (over 1000 ng/l and 100 µg/l, respectively) in both ischemic-heart-disease and non-
ischemic-heart-disease cases with postmortem intervals over 48h might basically be the consequence of 
postmortem change occurrence, with repercussions also on troponin levels in postmortem serum from 
femoral blood. 
These results would indicate that the time elapsed after death should be taken into consideration when 
cardiac troponins are measured in postmortem samples, since decompositional change onset involving 
myocytes might cause disruption of cell membrane integrity and thus release intracellular proteins into 
circulation or extracellular fluid, regardless of whether genuine myocardial ischemia is present or not. 
On the other hand, the possible influence of postmortem interval on troponin concentrations in 
postmortem samples has been repeatedly investigated in the past, with erratic results at times. For 
instance, Zhou et al. [19,20,23], Remmer et al. [30], and Chen et al. [33] observed postmortem interval-
dependent differences and elevations in troponin levels in various postmortem biological fluids, 
whereas Pérez-Carceles et al. [15] and Peter et al. [22] failed to notice significant correlations between 
cardiac troponins (measured in pericardial fluid and blood from femoral veins) and postmortem interval. 
It is worth noting, however, that according to the results of Peter et al. [22], troponin T measured in 
cardiac blood (unspecified sampling site) showed a significant positive correlation with autolysis time, 
troponin I a positive though not significant correlation with autolysis time, and both troponins no 
correlation with autolysis time when measured in femoral blood. 
A final point that deserves mentioning pertains to the absence of statistically significant differences 
between levels of all tested biomarkers (measured in postmortem serum from femoral blood) in cases 
without cardiopulmonary resuscitation and cases with cardiopulmonary resuscitation (at least for 
postmortem intervals up to 24 h). 
These findings are in agreement with those previously reported by Dressler et al. [11], Cina et al. [13], 
Pérez-Carceles et al. [15], and Ben Khalifa et al. [21] and do not differ substantially from those described 
in two clinical studies, thereby confirming the reliability of these postmortem results. 
Indeed, Polena et al. [36] observed that the duration of cardiopulmonary resuscitation was positively 
associated with troponin I elevation in 38 out of 68 selected patients (mean cardiopulmonary 
resuscitation duration 19.8 minutes), whereas 30 out of 68 patients (mean cardiopulmonary 
resuscitation duration 12.2 minutes) had negative troponin I levels after successful reanimation. In this 
study, troponin I concentrations were measured prior to, during and at least 8 hours following 
cardiopulmonary resuscitation.  
Lin et al. [37] found that cardiopulmonary resuscitation, even in the absence of defibrillation, can inflict 
cardiac injury, as evidenced by increased blood troponin I levels that peaked transiently around 16 h, 
though most patients had blood troponin I levels below 2 ng/ml immediately after spontaneous 
circulation return. 
Globally considered, these results would indicate that measurements of cardiac troponins in individuals 
who had been reanimated and for whom spontaneous circulation failed to return or did not return long 
enough after cardiopulmonary resuscitation (which may correspond to clinical troponin measurements 
“during reanimation”) fail to show increased troponin levels, possibly due to the fact that 
cardiocirculatory function was not (or not long enough) restored.  
This finding is significant because it might imply that increased troponin levels measured after death in 
individuals deceased after several hours of successful cardiopulmonary resuscitation might be difficult to 











the clinical setting in view of the specific kinetic pattern of serum troponin after resuscitation and in 
myocardial infarction. 
Some points of our study deserve to be stressed. The first is the fact that, as shown, in forensic cases 
with postmortem intervals over 48 h, the diagnostic weight of troponin T and I determination is limited, 
and the measured concentrations in postmortem serum do not reliably indicate the presence of 
antemortem myocardial ischemia. In practice, most forensic autopsies are performed more than 48 h 
after death and often the postmortem interval is unknown. Consequently, histology and 
immunohistochemistry remain irreplaceable basic tools for the diagnosis of myocardial ischemia in 
these cases. 
A second point that deserves to be emphasized is that, to address the second aim of the study, we 
included hanging and drug intoxication cases as control individuals. The choice of drug intoxication cases 
might appear problematic, considering that some of these individuals might have died after suffering 
from prolonged agony, gradual failure of the heart, and insufficient oxygen supply.  
It must be highlighted, however, that our study aimed to investigate the stability of NT-proBNP, 
troponin T, and troponin I in forensic cases having various postmortem intervals, but regardless of the 
hypoxic mechanism (ischemic or non-ischemic) responsible for the leakage of these compounds into the 
systemic circulation. In this regard, the choice of drug intoxication cases as control cases did not affect 
the general outcome of the study. 
To conclude, we believe that postmortem use of the biochemical markers of myocardial ischemia 
requires a fair amount of caution and flexibility, considering the utmost importance of postmortem 
interval duration before biological fluid collection and sampling site choice when interpreting obtained 
results. 
On the other hand, numerous researchers have emphasized that elevated troponin levels (in both 
postmortem serum and pericardial fluid) reflect myocardial damage severity from various causes and do 
not correlate specifically, necessarily or univocally with myocardial ischemia. This information must 
always be taken into account in order to avoid jumping to categorical conclusions in the absence of 
detailed arguments from all postmortem investigation findings. 
It is always worth remembering that pathologists should never yield to the temptation of establishing 
direct links between a single (postmortem) biochemical result and a probable cause of death. This is 
because postmortem biochemistry is a complementary discipline and appears completely useless when 
considered in isolation from the rest, though it can indeed offer a wealth of information when 
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Table 1 summarizes the measured values of troponin T, troponin I, and NT-proBNP in both studied 






Table 2 summarizes the main results of former studies performed on this topic 
 
Study  
(author(s) and year) 





Luna et al. 1982 
[1] 
Biochemical analysis in 
postmortem samples 
(several study groups 
including myocardial 
infarction) 
Pericardial fluid CK, LDH and 
their 
isoenzymes 
CK levels in the pericardial 
fluid significantly 
increased in myocardial 
infarction 
Luna et al. 1983 
[2] 
Biochemical analysis in 
postmortem samples 
(several study groups 
including myocardial 
infarction) 
Pericardial fluid CK isoenzymes The highest CK-MB values 
were found in the 
pericardial fluid in the 
myocardial infarction 
group 
Stewart et al. 1984 
[3] 
Biochemical analysis in 
postmortem samples 
(four study groups 
including cardiac 
deaths, resuscitation 
group and no 
resuscitation group) 
Pericardial fluid CK, LDH and 
their 
isoenzymes 
Measurements of cardiac 
enzymes in pericardial 
fluid may prove useful in 
establishing the 
postmortem diagnosis of 
acute myocardial injury 
Osuna et al. 1990 
[4] 



















The sample material of 
choice for biochemical 
tests (diagnosis of 
myocardial infarction) is 
the pericardial fluid.  
The most informative 
markers are myoglobin, 


















41-242 46-236 > 1.000 3-44 3-51 > 1.000 
Troponin I 
(µg/l) 
0.16-9.16 0.21-8.87 > 100 0.03-0.37 0.03-0.42 > 100 
NT-proBNP 
(ng/l) 












Burns et al. 1992 
[5] 
Biochemical analysis in 
postmortem samples 
(three study groups 
including death from 
myocardial infarction) 
Blood from right 
atrium 
Blood from a 
peripheral vein 
Pericardial fluid 
CK and CK 
isoenzymes 
Early myocardial 
infarction can be 
identified measuring CK 
isoenzymes  
Perez-Carceles et al. 
1995 
[6] 
Biochemical analysis in 
postmortem samples 

































The highest levels of CK, 
CK-MB, and LDH were 
observed in the 
pericardial fluid in cases 
with morphological 
evidence of myocardial 
ischemia 
Perez-Carceles et al. 
1995 
[7] 
Biochemical analysis in 
postmortem samples 











The highest levels of 
myosin were observed in 
serum and pericardial 
fluid in subjects who 
showed morphological 
evidence of myocardial 
ischemia 
Osuna et al. 1998 
[8] 
Biochemical analysis in 
postmortem samples 












The highest levels of all 
studied markers were 
observed in the 
pericardial fluid in 
subjects who had died 
from myocardial 
infarction 
Osuna et al. 1998 
[9] 
Biochemical analysis in 
postmortem samples 











The highest levels of 
myosin pericardial fluid 
were found in cases with 
morphological signs of 
myocardial infarction. 
The highest ration of 
pericardial fluid to serum 
myosin and myoglobin 
concentrations was found 
in the group of subjects 












Cina et al. 1998 
[10] 
Biochemical analysis in 










cardiac and non-cardiac 
causes of death in 
postmortem serum levels 
of both markers 
(cTnI concentrations > 40 
ng/ml only in cardiac 
deaths) 
Dressler et al. 1998 
[11] 
Biochemical analysis in 
postmortem samples 
(heart contusion vs 
resuscitation by heart 
massage) 










heart contusion vs heart 
massage 
Cina et al. 1999 
[12] 
Biochemical analysis in 




Pericardial fluid cTnI cTnI levels in the 
pericardial fluid up to six 
orders of magnitude 
above levels expected in 
serum. 
Cardiopulmonary 
resuscitation did not 
influence pericardial fluid 
cTnI levels 
Cina et al. 2001 
[13] 
Biochemical analysis in 
postmortem samples 




blood sampled at 





Positive results for cTnT in 
most cardiac cases. 
Cardiopulmonary 
resuscitation did not 
appear to result in  
false positive cases. 
Ellingsen and Hetland 
2004 
[14] 










cTnT cTnT may serve as a 
valuable tool to support 
the diagnosis of cardiac-
relate deaths in cases 
with inconclusive 
postmortem 
morphological findings  
Pérez-Carceles et al. 
2004 
[15] 
Biochemical analysis in 
postmortem samples 
(ischemic heart disease 












differences in pericardial 
fluid for all the 
biochemical markers in 
ischemic heart disease 
cases. 
No statistically significant 
correlations between the 
levels of the analyzed 











postmortem interval or 







Biochemical analysis in 
postmortem samples 
(three sudden death 









LDH, CK-NAC and CK-MB 
measurement in plasma, 
pericardial fluid and 
vitreous did not provide 
valuable additional 
information in cases of 
sudden death. 
 
CK-NAC and CK-MB values 
in pericardial fluid were 
more elevated in cases of 
atheromatous occlusive 




CK-NAC and CK-MB values 
in vitreous were more 
elevated in cases of 
myocardial infarction 















Erratic results bearing 
little or no relation 
between antemortem 
and postmortem levels 
















differences for all the 
studied markers in the 
pericardial fluid.  
The highest levels in the 
group of cases who have 
died from myocardial 
infarction 
Zhu et al. 2006 
[19] 
Biochemical analysis in 
postmortem samples 




Blood from left 
and right heart 
chambers as well 
as external iliac 
vein  
cTnT Elevated postmortem 
serum and pericardial 
cTnT levels occur 
depending on the severity 
of myocardial damage 
from various causes, 












Zhu et al. 2006 
[20] 
Biochemical analysis in 
postmortem samples 




Blood from left 
and right heart 
chambers as well 
as external iliac 
vein  
cTnT Elevation in postmortem 
serum and pericardial 
fluid cTnT levels in sudden 
death may depend on the 
severity of ischemic 
myocardial damage, and 
on the postmortem 
interval for heart blood 
and pericardial fluid levels 
Ben Khalifa et al. 2006 
[21] 
Biochemical analysis in 
postmortem samples 
(sudden cardiac deaths 





cTnT Increased cTnT levels in 




resuscitated cases were 
not statistically significant 
Peter et al. 2006 
[22] 
Biochemical analysis in 
postmortem samples 
(cardiac contusion and 
control cases) 
Cardiac blood 
and blood from 
femoral veins 
Troponin I, T 
and C 
Troponin values in cardiac 
blood much higher than 
those measured in the 
venous blood. 
Significant positive 
correlation autolysis – 
cardiac blood troponin T 
value. 
No correlation (femoral) 
autolysis - venous blood 
troponin values. 
Zhu et al. 2007 
[23] 
Biochemical analysis in 
postmortem samples 
(several study groups 
including myocardial 




Blood from left 
and right heart 
chambers as well 





dependent elevation of 
both markers in cardiac 
blood, peripheral blood, 
and pericardial fluid. 
Elevated cTnI and CK-MB 
levels in blood and 
pericardial fluid are 
related to ischemic, 
hypoxic, and/or cytotoxic 
myocardial damage 
Sidlo e al. 2008 
[24] 
Biochemical analysis in 
postmortem samples 
(sudden cardiac deaths 
vs control cases) 
Blood from left 
cardiac ventricle 




Blood cTnI and pro-ANP 
levels are not useful for 
the postmortem diagnosis 
of myocardial damage  
Vargas et al. 2008 
[25] 
Biochemical analysis in 
postmortem samples 






cTnI cTnI did not correlate 
specifically with ischemia 
or infarction.  











chronic ischemic heart 





Maeda et al. 2009 
[26] 
Biochemical analysis in 
postmortem samples 
(several study groups 
including acute 
myocardial infarction 








Cerebrospinal fluid levels 
of cTnT and cTnI are 
useful for investigating 
process and duration of 
myocardial damage in the 
death process. 




Batalis et al. 2010 
[27] 
Biochemical analysis in 
postmortem samples 
(ischemic heart disease 
vs control cases) 
Pericardial fluid 


















Wang et al. 2011 
[28] 
Biochemical analysis in 
postmortem samples 
(several study groups 








Combined analysis of  
CK-MB, cTnI and 
myoglobin in pericardial 
and cerebrospinal fluids 
are helpful for evaluating 
the severity of 
myocardial/skeletal 
muscle damage in death 
process 
Sapouna et al. 2013 
[29] 
Biochemical analysis in 
postmortem samples 
(ischemic heart disease 
vs control cases) 
Pericardial fluid cTnI Statistically significant 
differences in pericardial 
fluid cTnI in ischemic 
heart disease cases 
Remmer et al. 2013 
[30] 
Biochemical analysis in 
postmortem samples 









cTnT Overlapping values 
between the studied 
groups making difficult to 
apply results in individual 
cases.  
Postmortem time- 
dependent elevations in 
cTnT levels have to be 
taken into consideration 
Ghormade et al. 2014 
[31] 
Biochemical analysis in 
postmortem samples 
(several study groups 
Pericardial fluid CK-MB 
LDH 
The role of CK-MB in 
pericardial fluid as a 












cardiac death due to 
ischemic heart disease) 
definite detection of 
myocardial infarction in 
cases of sudden cardiac 
death is limited. 
LDH is not useful for 
postmortem diagnosis of 
myocardial infarction 
Ghormade et al. 2014 
[32] 
Biochemical analysis in 
postmortem samples 
(several study groups 
including sudden 
cardiac death due to 
ischemic heart disease) 
Pericardial fluid CK-MB 
 
The highest levels of  
CK-MB in pericardial fluid 
were noted in deaths due 
to ischemic heart disease 
Chen et al. 2015 
[33] 
Biochemical analysis in 
postmortem samples 














Cause of death and 
postmortem time 
dependent differences. 
No differences between 
myocardial infarction and 
other causes of death. 
Elevated levels are not a 
specific finding for 
ischemic heart disease 
death but indicate the 
severity of myocardial 
injury. 
Gonzalez-Herrera et al. 
2016 
[34] 
Biochemical analysis in 
postmortem samples 











cTnT levels stable in both 
postmortem serum from 
femoral blood and 
pericardial fluid for up to 
34 h after death. 
Markedly higher levels in 
both postmortem 
samples than in in vivo 
samples. 
Low cTnT levels in 
pericardial fluid may 
exclude cardiac damage. 
Carvajal-Zarrabal et al. 
2017 
[35] 
Biochemical analysis in 
postmortem samples 
(sudden cardiac death 









Postmortem levels of cTnI 
and cTnT are useful to 
support a sudden cardiac 
death diagnosis in the 
first 12 h after death 
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